Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilmott

Showing results (51-60 of 162) with videos related to

Pageof 17
Sort By:
Oncoimmunology|October 9, 2023
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapiesTuba N Gide, Elizabeth C Paver, Zarwa Yaseen, et al.
Scientific Data|November 7, 2018
Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical featuresMatthew P Salomon, Javier I J Orozco, James S Wilmott, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Histopathology|December 28, 2018
Inter- and intrapatient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironmentTuba N Gide, Benjamin M Allanson, Alexander M Menzies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma PatientsHojabr Kakavand, James S Wilmott, Alexander M Menzies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patientsHojabr Kakavand, Louise A Jackett, Alexander M Menzies, et al.
The Journal of Experimental Medicine|March 15, 2023
Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosisAndrew J Sawyer, Ellis Patrick, Jarem Edwards, et al.
Oncogene|October 15, 2013
Oncogenic suppression of PHLPP1 in human melanomaL Dong, L Jin, H-Y Tseng, et al.
Cancer Research|September 27, 2017
Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative StressJia Yu Wang, Guang Zhi Liu, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic TumorsIsmael A Vergara, Nigel G Maher, Alison J Potter, et al.
Pageof 17

Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
Oncoimmunology|October 9, 2023
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapiesTuba N Gide, Elizabeth C Paver, Zarwa Yaseen, et al.
Scientific Data|November 7, 2018
Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical featuresMatthew P Salomon, Javier I J Orozco, James S Wilmott, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Histopathology|December 28, 2018
Inter- and intrapatient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironmentTuba N Gide, Benjamin M Allanson, Alexander M Menzies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma PatientsHojabr Kakavand, James S Wilmott, Alexander M Menzies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patientsHojabr Kakavand, Louise A Jackett, Alexander M Menzies, et al.
The Journal of Experimental Medicine|March 15, 2023
Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosisAndrew J Sawyer, Ellis Patrick, Jarem Edwards, et al.
Oncogene|October 15, 2013
Oncogenic suppression of PHLPP1 in human melanomaL Dong, L Jin, H-Y Tseng, et al.
Cancer Research|September 27, 2017
Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative StressJia Yu Wang, Guang Zhi Liu, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic TumorsIsmael A Vergara, Nigel G Maher, Alison J Potter, et al.
Pageof 17